Infectious Diseases Clinical Trials Offering Full Safety and Confidentiality
Expanding the Science for Effective Preventions and Treatments
A Phase 3 clinical trial to evaluate the Pfizer quadrivalent modified RNA (modRNA) influenza vaccine | |
A COVID-19 study to evaluate a combination of two monoclonal-antibodies, Tixagevimab and Cilgavimab, for pre-exposure prophylaxis (prevention) | |
A Phase 3 clinical study to evaluate a vaccine candidate for the prevention of RSV (Respiratory Syncytial Virus) | |
A Phase 3 master protocol to evaluate additional dose(s) of Pfizer COVID-19 vaccine in healthy 12 to 30 year old individuals previously vaccinated |
Infectious diseases research delivers new therapies by translating clinical trial results into patient care treatment and infection prevention guidelines. At CARE-ID we are dedicated to providing excellent research studies and exceptional patient care.
Our research has broad application because infectious diseases can involve nearly every medical specialty. Successful studies lead to published results that give doctors and nurses essential information across a wide range of care needs; from primary care, to hospital care, to rehabilitation care, and more.
Infectious diseases specialists are often referred to as medical detectives. Years of experience along with timely, well-designed research provide the foundation for advancing treatments and prevention methods to the level of best practices in medical care.